Sienna Biopharmaceuticals, Inc. Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sienna Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sienna Biopharmaceuticals, Inc. for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 319,421 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 211,934 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 563,072 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 2,538,641 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 319,421 | 0 | 882,493 | 563.1 K to 882.5 K (+56.73 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 563,072 | 0 | 563,072 | 0 to 563.1 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 211,934 | 0 | 2,750,575 | 2.5 M to 2.8 M (+8.35 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 2,538,641 | 0 | 2,538,641 | 0 to 2.5 M |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Stroehmann Diane | See Remarks | Option Exercise | C | 0.00 | 28,153 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Stroehmann Diane | See Remarks | Buy | P | 15.00 | 7,000 | 105,000 | 124,724 | 117.7 K to 124.7 K (+5.95 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Stroehmann Diane | See Remarks | Buy | C | 0.00 | 28,153 | 0 | 117,724 | 89.6 K to 117.7 K (+31.43 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | PETERSON RICHARD D | Chief Financial Off ... | Buy | P | 15.00 | 7,000 | 105,000 | 7,000 | 0 to 7 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 319,421 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 211,934 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 563,072 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,538,641 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 319,421 | 0 | 882,493 | 563.1 K to 882.5 K (+56.73 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 563,072 | 0 | 563,072 | 0 to 563.1 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 211,934 | 0 | 2,750,575 | 2.5 M to 2.8 M (+8.35 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,538,641 | 0 | 2,538,641 | 0 to 2.5 M |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | MORE ROBERT J | Director | Option Exercise | C | 0.00 | 32,892 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | MORE ROBERT J | Director | Option Exercise | C | 0.00 | 136,286 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | MORE ROBERT J | Director | Buy | C | 0.00 | 32,892 | 0 | 203,249 | 170.4 K to 203.2 K (+19.31 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | MORE ROBERT J | Director | Buy | C | 0.00 | 136,286 | 0 | 170,357 | 34.1 K to 170.4 K (+400.01 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | MAST ERLE T | Director | Buy | P | 15.00 | 6,700 | 100,500 | 6,700 | 0 to 6.7 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | C | 0.00 | 10,557 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Buy | P | 15.00 | 10,000 | 150,000 | 94,634 | 84.6 K to 94.6 K (+11.82 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Lizzul Paul F. | Chief Medical Offic ... | Buy | C | 0.00 | 10,557 | 0 | 10,557 | 0 to 10.6 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Leonard Keith R | Director | Option Exercise | C | 0.00 | 31,784 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Leonard Keith R | Director | Buy | P | 15.00 | 16,700 | 250,500 | 16,700 | 0 to 16.7 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Leonard Keith R | Director | Buy | C | 0.00 | 31,784 | 0 | 31,784 | 0 to 31.8 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 319,421 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 211,934 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 563,072 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 2,538,641 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Buy | C | 0.00 | 319,421 | 0 | 882,493 | 563.1 K to 882.5 K (+56.73 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Buy | C | 0.00 | 563,072 | 0 | 563,072 | 0 to 563.1 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Buy | C | 0.00 | 211,934 | 0 | 2,750,575 | 2.5 M to 2.8 M (+8.35 %) |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Burow Kristina | Director | Buy | C | 0.00 | 2,538,641 | 0 | 2,538,641 | 0 to 2.5 M |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | C | 0.00 | 112,614 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | C | 0.00 | 14,076 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Option Exercise | C | 0.00 | 14,076 | 0 | 0 | |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Buy | C | 0.00 | 112,614 | 0 | 112,614 | 0 to 112.6 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Buy | C | 0.00 | 14,076 | 0 | 14,076 | 0 to 14.1 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Beddingfield III Frederick | President & CEO | Buy | C | 0.00 | 14,076 | 0 | 14,076 | 0 to 14.1 K |
| Aug 01 2017 | SNNA | Sienna Biopharmace ... | Andrews Timothy K. | General Counsel & S ... | Buy | P | 15.00 | 15,000 | 225,000 | 15,000 | 0 to 15 K |